PTT-A (Quadruple Receptor Agonist) 10mg

$95.00

PTT-A is an investigational molecule that combines agonism at GLP-1, GIP, amylin and calcitonin receptors—a departure from dual and triple agonist approaches. Early cell and rodent studies have reported receptor activity and body-composition effects, but the compound is still preclinical, its reference structure has not been made public, and its relevance to humans is unknown. For researchers, it underscores the importance of receptor pharmacology, structural characterization and rigorous testing.